News | Treatment Planning | September 08, 2015

Technology reduced treatment time for five tumors from three hours to under 20 minutes

Brainlab, Automatic Brain Metastases Planning software, first U.S. patient, Jefferson Hospital for Neuroscience, Philadelphia

September 8, 2015 — Brainlab announced that its Automatic Brain Metastases Planning software has been used for the first time in the United States at Jefferson Hospital for Neuroscience in Philadelphia. The software was used to deliver a tailored radiosurgery treatment to a patient with cancer that has metastasized to the brain. The procedure, in which all five of the patient’s brain metastases were treated, took less than 20 minutes, including setup time using the Brainlab technology. Using the traditional method, it could have taken three hours or roughly 30 minutes per tumor.

When treating such patients, Automatic Brain Metastases Planning offers improvements over the current standard of whole brain radiation therapy (WBRT) treatment. WBRT involves applying low doses of radiation to the entire brain over time and with many sessions, which can lead to cognitive deficits. Automatic Brain Metastases Planning software can automatically render a clinically ready treatment plan typically in less than two minutes.

Using a unique dedicated algorithm, the Brainlab software allows delivery of highly conformal single-session treatments while helping to minimize dose spread to surrounding healthy tissue. By treating multiple brain metastases at one time, planning and treatment time can be significantly reduced, even with as many as 10 tumors to treat.  

“In our first patient treatment, we targeted five metastatic brain tumors in one frameless treatment session,” commented David W. Andrews, M.D., professor in the Department of Neurosurgery, director of the Division of Neuro-oncologic Neurosurgery and Stereotactic Radiosurgery. “We will continue to use the Brainlab software with ExacTrac patient positioning and monitoring to efficiently and effectively treat up to 10 metastatic tumors at once, helping prevent unnecessary loss of brain function that can occur with whole brain radiation therapy, such as memory loss or other cognitive deficits.”

"With traditional stereotactic radiosurgery techniques, each metastasis is planned and treated individually, thereby increasing treatment time,” said Wenyin Shi, M.D., Ph.D., assistant professor of radiation oncology, medical director of radiation oncology at Jefferson Hospital for Neurosciences, and co-director of the Jefferson Brain Tumor Program. “The Brainlab software allows us to deliver a conformal cranial SRS plan with time-efficient precision targeting of several metastases in a single session.”

“Patients with diseases that cause brain lesions often require multiple treatments that are lengthy and cause discomfort. We are enthusiastic about any advances in practice that can limit the time a patient needs to undergo treatment and minimalize distress,” added Andrews.

Automatic Brain Metastases Planning is part of the Brainlab Elements a la carte software modules that support and facilitate neurosurgery and radiation oncology treatment planning

For more information: www.brainlab.com


Related Content

News | Radiology Education

April 21, 2025 — On June 20, the American Society of Radiologic Technologists (ASRT) will award Life Member status to ...

Time April 21, 2025
arrow
News | Radiology Business

April 16, 2025 — According to a new report, the U.S. Radiotherapy Market is projected to reach $2.49 billion by 2030 ...

Time April 17, 2025
arrow
News | ASTRO

March 14, 2025 — Another pivotal milestone in the nation’s fight against cancer recently took place with the ...

Time March 17, 2025
arrow
News | Computed Tomography (CT)

Royal Philips recently received 510(k) clearance from the US Food and Drug Administration (FDA) for its detector-based ...

Time November 13, 2024
arrow
News

Aug. 5, 2024 — Researchers from The University of Texas MD Anderson Cancer Center have demonstrated that adding ...

Time August 09, 2024
arrow
News | PET-CT

July 31, 2024 — In a head-to-head comparison with FDG PET/CT, FDG PET/MRI demonstrated comparable or superior diagnostic ...

Time July 31, 2024
arrow
Feature | Radiation Oncology | By Christine Book

News emerging from several leading organizations and vendors in the radiation therapy arena came in at a fast pace in ...

Time July 30, 2024
arrow
News | Radiation Oncology

July 11, 2024 — The American Society for Radiation Oncology (ASTRO) issued the following statement from Jeff M ...

Time July 11, 2024
arrow
News | Radiation Oncology

July 9, 2024 — Insights from the latest Mordor Intelligence report, “Radiotherapy Market Size & Share Analysis - Growth ...

Time July 09, 2024
arrow
News | Prostate Cancer

July 5, 2024 — Lantheus Holdings, Inc., a leading radiopharmaceutical-focused company committed to enabling clinicians ...

Time July 05, 2024
arrow
Subscribe Now